Consun Pharmaceutical (1681.HK) traded up 1.12 % during a 24 hours period ending at 07:57 PM Central Europe on Monday 26th. One Consun Pharmaceutical stock can currently be bought for about HKD 15.6 on popular exchanges. Current supply of Consun Pharmaceutical stocks is 838.8 mn. Consun Pharmaceutical has a current market capitalization of HKD 12.9 bn and approximately HKD 23 mn worth of Consun Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Consun Pharmaceutical has traded 6.22 % up. Simple moving average of last 200 days is at HKD 15.22. The highest price of past 52 weeks was recorded at HKD 19.35 on 02/20/2026. 52 weeks low was at HKD 12.31 on 06/24/2026.

Here is how related stocks have performed in the past 24 hours:

  • Rlx (RLX) traded down -1.83 % and now trades at USD 1.66. Rlx has a market capitalisation of USD 2 bn. Rlx has a current price to earnings ratio of 14.49.

  • Inner Mongolia Shuangxin E (001369.SZ) traded flat 0 % and now trades at CNY 11.37. Current market capitalisation for Inner Mongolia Shuangxin E is CNY 13.2 bn. Inner Mongolia Shuangxin E has a current price to earnings ratio of 18.5.

  • Shenzhen Airport (000089.SZ) traded flat 0 % and now trades at CNY 6.48. Shenzhen Airport has a market capitalisation of CNY 13.1 bn. Current price/earnings ratio for Shenzhen Airport is 13.74.

  • Guangdong Huate Gas (688268.SS) traded flat 0 % and now trades at CNY 101.35. Guangdong Huate Gas has a market capitalisation of CNY 13.1 bn. Guangdong Huate Gas has a current price to earnings ratio of 98.6.

  • Nanjing King-friend Bioche (603707.SS) traded flat 0 % and now trades at CNY 8.3. Current market capitalisation for Nanjing King-friend Bioche is CNY 13.2 bn. Nanjing King-friend Bioche has a current price to earnings ratio of 26.8.


About Consun Pharmaceutical

The Consun Pharmaceutical Group Ltd. is a pharmaceutical company based in Guangzhou, China, that specializes in the research, manufacturing, and sale of modern Chinese medicines and medical contrast media within the People’s Republic of China.